MarketCap
Facebook
X
TelegramQuartalsbericht 2025-Q3
hinzugefügt 04.11.2025
Corcept Therapeutics Incorporated ROE 2011-2026 | CORT
ROE Jährlich Corcept Therapeutics Incorporated
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 20.78 | 20.95 | 20.21 | 29.94 | 20.26 | 25.37 | 27.33 | 67.61 | 19.67 | -34.64 | 926.3 | -218.92 | -61.59 | -92.95 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 926.3 | -218.92 | 55.02 |
ROE Vierteljährlich Corcept Therapeutics Incorporated
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 19.04 | 21.88 | 21.42 | 25.21 | 24.34 | 21.39 | 23.64 | 24.15 | 23.82 | 19.1 | 24.74 | 23.07 | 21.95 | 15.31 | 20.28 | 18.77 | 19.11 | 20.26 | 23.21 | 26.17 | 26.19 | 25.37 | 25.44 | 24.77 | 25.93 | 27.33 | 70.85 | 71.62 | 71.65 | 67.61 | 27.23 | 26.28 | 22.02 | 19.67 | 13.75 | 4.25 | -8.58 | -34.64 | 75.14 | 255.66 | 489.03 | 926.3 | 758.41 | 529.24 | 249.73 | -218.92 | -184.0 | -145.53 | -101.22 | -61.59 | -72.13 | -77.19 | -90.41 | -92.95 | -18.49 | -25.52 | -20.4 |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 926.3 | -218.92 | 54.71 |
ROE anderer Aktien in der Pharmaeinzelhändler
| Name | ROE | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
15.76 | - | 2.43 % | $ 254 M |  Germany |
 |
ARCA biopharma
ABIO
|
-21.9 | - | 1052.0 % | $ 415 M |  USA |
 |
Adaptive Biotechnologies Corporation
ADPT
|
-78.68 | $ 18.33 | -0.92 % | $ 2.7 B | USA |
 |
Amgen
AMGN
|
69.59 | $ 343.48 | 0.47 % | $ 184 B | USA |
 |
Arrowhead Pharmaceuticals
ARWR
|
-0.35 | $ 72.81 | 5.02 % | $ 9.74 B | USA |
 |
I-Mab
IMAB
|
-85.31 | - | - | $ 866 M |  China |
 |
Aytu BioScience
AYTU
|
-71.51 | $ 2.72 | 4.62 % | $ 17.1 M | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
5.18 | - | - | $ 40.3 B | USA |
 |
Adagene
ADAG
|
-66.16 | $ 2.99 | 8.55 % | $ 168 M | China |
 |
Biogen
BIIB
|
9.76 | $ 177.96 | -1.07 % | $ 25.9 B | USA |
 |
Biophytis SA
BPTS
|
-751.94 | - | -13.47 % | $ 169 M |  France |
 |
Midatech Pharma plc
MTP
|
-330.29 | - | -18.52 % | $ 27.3 M |  Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
-115.61 | - | -1.52 % | $ 24.7 M | USA |
 |
Akero Therapeutics
AKRO
|
-33.6 | - | - | $ 3.67 B | USA |
 |
Alterity Therapeutics Limited
ATHE
|
-36.22 | $ 3.12 | -1.74 % | $ 7.51 B |  Australia |
 |
Acorda Therapeutics
ACOR
|
160.08 | - | -24.86 % | $ 820 K | USA |
 |
Aptose Biosciences
APTO
|
559.76 | - | -45.71 % | $ 1.2 M |  Canada |
 |
Acasti Pharma
ACST
|
-14.36 | - | 4.01 % | $ 150 M | Canada |
 |
Aeglea BioTherapeutics
AGLE
|
-40.17 | - | - | $ 1.01 B | USA |
 |
Akebia Therapeutics
AKBA
|
169.78 | $ 1.4 | -0.71 % | $ 262 M | USA |
 |
Albireo Pharma
ALBO
|
-19.38 | - | -0.23 % | $ 916 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
17.55 | - | - | - |  Russia |
 |
Allena Pharmaceuticals
ALNA
|
-257.91 | - | 3.16 % | $ 1.9 M | USA |
 |
Ascendis Pharma A/S
ASND
|
-43.41 | $ 223.74 | -1.05 % | $ 5 B |  Danmark |
 |
Ampio Pharmaceuticals
AMPE
|
-256.9 | - | -11.43 % | $ 502 K | USA |
 |
Burford Capital Limited
BUR
|
10.1 | $ 9.85 | 1.65 % | $ 1.59 B | Britain |
 |
Applied Molecular Transport
AMTI
|
-207.64 | - | - | $ 10.1 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
-144.96 | $ 4.13 | 2.92 % | $ 8.99 B |  Israel |
 |
Aravive
ARAV
|
-716.17 | - | -13.39 % | $ 1.45 M | USA |
 |
BioNTech SE
BNTX
|
1.11 | $ 110.82 | -2.58 % | $ 27.2 B | Germany |
 |
Athira Pharma
ATHA
|
-216.19 | - | - | $ 269 M | USA |
 |
Aeterna Zentaris
AEZS
|
-401.79 | - | 5.93 % | $ 314 M | Canada |
 |
Autolus Therapeutics plc
AUTL
|
-51.64 | $ 1.39 | 1.09 % | $ 355 M | Britain |
 |
AgeX Therapeutics
AGE
|
-270.67 | - | -10.17 % | $ 12.2 K | USA |
 |
AVROBIO
AVRO
|
12.83 | - | 1083.1 % | $ 745 M | USA |
 |
Cardiff Oncology
CRDF
|
-54.77 | $ 1.72 | -2.0 % | $ 82 M | USA |
 |
Akouos
AKUS
|
-37.09 | - | 0.23 % | $ 488 M | USA |
 |
Adaptimmune Therapeutics plc
ADAP
|
-288.19 | - | -15.15 % | $ 60.3 M | Britain |
 |
Brickell Biotech
BBI
|
-57.34 | - | -5.38 % | $ 6.06 M | USA |
 |
Amneal Pharmaceuticals
AMRX
|
67.61 | $ 14.17 | 3.55 % | $ 4.38 B | USA |
 |
Compugen Ltd.
CGEN
|
-25.92 | $ 1.85 | 0.27 % | $ 166 M | Israel |
 |
AIkido Pharma
AIKI
|
-36.89 | - | 1.93 % | $ 17.4 M | USA |
 |
Atreca
BCEL
|
-123.92 | - | -11.76 % | $ 5.79 M | USA |
 |
CureVac N.V.
CVAC
|
-59.8 | - | - | $ 867 M | Germany |
 |
Acer Therapeutics
ACER
|
156.54 | - | 2.71 % | $ 14 M | USA |
 |
BioCryst Pharmaceuticals
BCRX
|
18.68 | $ 6.68 | 1.52 % | $ 1.38 B | USA |
 |
Alpine Immune Sciences
ALPN
|
-32.19 | - | - | $ 2.17 B | USA |
 |
AlloVir
ALVR
|
-51.87 | - | 4.14 % | $ 49.1 M | USA |
 |
Beam Therapeutics
BEAM
|
-51.36 | $ 28.17 | 1.99 % | $ 2.32 B | USA |
 |
BeiGene, Ltd.
BGNE
|
-19.35 | - | 0.49 % | $ 251 B |  Cayman-islands |